<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="4.3.2">Jekyll</generator><link href="https://calebaguayo.github.io/McNuttLab/feed.xml" rel="self" type="application/atom+xml" /><link href="https://calebaguayo.github.io/McNuttLab/" rel="alternate" type="text/html" /><updated>2024-08-14T18:46:24+00:00</updated><id>https://calebaguayo.github.io/McNuttLab/feed.xml</id><title type="html">McNutt Lab Website</title><subtitle>Explore the innovative research of a distinguished scientist and educator dedicated to unraveling the mysteries of toxicity and regeneration. Delve into cutting-edge studies ranging from molecular mechanisms to multi-organ responses, aimed at developing transformative therapies for human diseases. Join us in advancing scientific frontiers, fostering creativity, excellence, and mentorship for the scientists of tomorrow.</subtitle><entry><title type="html">New Research Shows Drug Used to Treat Neuromuscular Weakness Could Counter Botulism</title><link href="https://calebaguayo.github.io/McNuttLab/2022/08/01/WakeNeuromuscular.html" rel="alternate" type="text/html" title="New Research Shows Drug Used to Treat Neuromuscular Weakness Could Counter Botulism" /><published>2022-08-01T00:00:00+00:00</published><updated>2024-08-14T18:45:12+00:00</updated><id>https://calebaguayo.github.io/McNuttLab/2022/08/01/WakeNeuromuscular</id><content type="html" xml:base="https://calebaguayo.github.io/McNuttLab/2022/08/01/WakeNeuromuscular.html"><![CDATA[<p>Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are investigating a drug used to treat neuromuscular weakness as a potential treatment for botulism, a rare but serious disease</p>]]></content><author><name>Wake Forest University School of Medicine</name></author><category term="biology" /><category term="medicine" /><summary type="html"><![CDATA[Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are investigating a drug used to treat neuromuscular weakness as a potential treatment for botulism, a rare but serious disease]]></summary><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://calebaguayo.github.io/McNuttLab/images/Posts/wake.jpg" /><media:content medium="image" url="https://calebaguayo.github.io/McNuttLab/images/Posts/wake.jpg" xmlns:media="http://search.yahoo.com/mrss/" /></entry><entry><title type="html">Trojan Horse Antidotes Designed to Neutralize Lethal Botulinum Toxin</title><link href="https://calebaguayo.github.io/McNuttLab/2021/01/11/TrojanHorse.html" rel="alternate" type="text/html" title="Trojan Horse Antidotes Designed to Neutralize Lethal Botulinum Toxin" /><published>2021-01-11T00:00:00+00:00</published><updated>2024-08-14T18:45:12+00:00</updated><id>https://calebaguayo.github.io/McNuttLab/2021/01/11/TrojanHorse</id><content type="html" xml:base="https://calebaguayo.github.io/McNuttLab/2021/01/11/TrojanHorse.html"><![CDATA[<p>Two research groups have designed chimeric fusion proteins that constitute a new “trojan horse” approach to neutralize lethal botulinum toxins.</p>]]></content><author><name>Genetic Engineering &amp; Biotechnology News</name></author><category term="biology" /><category term="medicine" /><summary type="html"><![CDATA[Two research groups have designed chimeric fusion proteins that constitute a new “trojan horse” approach to neutralize lethal botulinum toxins.]]></summary><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://calebaguayo.github.io/McNuttLab/images/Posts/lead-image-e1681832925603.webp" /><media:content medium="image" url="https://calebaguayo.github.io/McNuttLab/images/Posts/lead-image-e1681832925603.webp" xmlns:media="http://search.yahoo.com/mrss/" /></entry><entry><title type="html">New strategy to fight botulinum toxin - expert available</title><link href="https://calebaguayo.github.io/McNuttLab/2021/01/06/BotToxEurekA.html" rel="alternate" type="text/html" title="New strategy to fight botulinum toxin - expert available" /><published>2021-01-06T00:00:00+00:00</published><updated>2024-08-14T18:45:12+00:00</updated><id>https://calebaguayo.github.io/McNuttLab/2021/01/06/BotToxEurekA</id><content type="html" xml:base="https://calebaguayo.github.io/McNuttLab/2021/01/06/BotToxEurekA.html"><![CDATA[<p>Related to new research published in the January issue of Science Translational Medicine, Patrick McNutt, PhD, of the Wake Forest Institute for Regenerative Medicine, was part of the research team that demonstrated a new “Trojan horse” approach that produces strong antidotal efficacy in treating lethal botulism in mice, guinea pigs and rhesus macaque monkeys.</p>]]></content><author><name>EurekAlert!</name></author><summary type="html"><![CDATA[Related to new research published in the January issue of Science Translational Medicine, Patrick McNutt, PhD, of the Wake Forest Institute for Regenerative Medicine, was part of the research team that demonstrated a new “Trojan horse” approach that produces strong antidotal efficacy in treating lethal botulism in mice, guinea pigs and rhesus macaque monkeys.]]></summary><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://calebaguayo.github.io/McNuttLab/images/Posts/800px-Botulinum_toxin_3BTA.png" /><media:content medium="image" url="https://calebaguayo.github.io/McNuttLab/images/Posts/800px-Botulinum_toxin_3BTA.png" xmlns:media="http://search.yahoo.com/mrss/" /></entry><entry><title type="html">Patrick McNutt Talks Chemical Weapons</title><link href="https://calebaguayo.github.io/McNuttLab/2015/04/20/BioChemWeapons.html" rel="alternate" type="text/html" title="Patrick McNutt Talks Chemical Weapons" /><published>2015-04-20T00:00:00+00:00</published><updated>2024-08-14T18:45:12+00:00</updated><id>https://calebaguayo.github.io/McNuttLab/2015/04/20/BioChemWeapons</id><content type="html" xml:base="https://calebaguayo.github.io/McNuttLab/2015/04/20/BioChemWeapons.html"><![CDATA[<p>Army scientist discusses medical research being carried out to understand and protect against warfare agents</p>

<p>Just four days after defending a Ph.D. in molecular biology at Princeton University, Patrick McNutt started basic infantry training at Fort Benning, Ga. “That led to some culture shock,” he recalls with a chuckle. But the experience prepared him to deploy in 2005–06 to Iraq, where he provided science and technology ground support as a member of the Reserve Officers’ Training Corps, a military program that financially supported the bachelor’s degree he received from Wake Forest University.</p>

<p>Today, McNutt, who clearly doesn’t relish a humdrum life, works for the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), the primary laboratory of the Department of Defense for investigating medical aspects of chemical weapons defense. He studies the biological and biochemical mechanisms of nerve agents, mustard gas, and botulinum neurotoxins. What follows is a recent discussion (edited for length and clarity) he had with C&amp;EN about why chemical weapons defense research is relevant today.</p>

<p><a href="https://cen.acs.org/articles/93/i16/Patrick-McNutt-Talks-Chemical-Weapons.html">Original post</a></p>]]></content><author><name>Biological Chemistry</name></author><category term="biology" /><category term="medicine" /><summary type="html"><![CDATA[Army scientist discusses medical research being carried out to understand and protect against warfare agents]]></summary><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://calebaguayo.github.io/McNuttLab/images/Posts/09316-scitech2-McNutt.jpg" /><media:content medium="image" url="https://calebaguayo.github.io/McNuttLab/images/Posts/09316-scitech2-McNutt.jpg" xmlns:media="http://search.yahoo.com/mrss/" /></entry></feed>